Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses

Y Chen, X Zhao, H Zhou, H Zhu, S Jiang… - Nature Reviews …, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …

An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment

S Drożdżal, J Rosik, K Lechowicz, F Machaj… - Drug Resistance …, 2021 - Elsevier
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …

[HTML][HTML] Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions

AI Abulsoud, HM El-Husseiny, AA El-Husseiny… - Biomedicine & …, 2023 - Elsevier
COVID-19 is a worldwide pandemic caused by SARS-coronavirus-2 (SARS-CoV-2). Less
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …

Aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2: Nanoscale electrode-aptamer-SARS-CoV-2 imaging by photo-induced force …

JC Abrego-Martinez, M Jafari, S Chergui… - Biosensors and …, 2022 - Elsevier
Rapid, mass diagnosis of the coronavirus disease 2019 (COVID-19) is critical to stop the
ongoing infection spread. The two standard screening methods to confirm the severe acute …

Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro

S Bharadwaj, A Dubey, U Yadava… - Briefings in …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a dreaded pandemic in lack of specific …

D‐dimer, CRP, PCT, and IL‐6 Levels at Admission to ICU Can Predict In‐Hospital Mortality in Patients with COVID‐19 Pneumonia

M Milenkovic, A Hadzibegovic, M Kovac… - Oxidative medicine …, 2022 - Wiley Online Library
Introduction. Health care workers have had a challenging task since the COVID‐19
outbreak. Prompt and effective predictors of clinical outcomes are crucial to recognize …

Evaluation of anti-SARS-Cov-2 S-RBD IgG antibodies after COVID-19 mRNA BNT162b2 vaccine

B Lo Sasso, RV Giglio, M Vidali, C Scazzone, G Bivona… - Diagnostics, 2021 - mdpi.com
(1) Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD)
antibodies represents a useful tool to estimate the individual protection against Severe …

The origins of COVID‐19 pandemic: A brief overview

YJ Hao, YL Wang, MY Wang, L Zhou… - Transboundary and …, 2022 - Wiley Online Library
The novel coronavirus disease (COVID‐19) outbreak that emerged at the end of 2019 has
now swept the world for more than 2 years, causing immeasurable damage to the lives and …

SARS-CoV-2 infection: new molecular, phylogenetic, and pathogenetic insights. Efficacy of current vaccines and the potential risk of variants

JC Rotondo, F Martini, M Maritati, C Mazziotta… - Viruses, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly discovered
coronavirus responsible for the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 …

Effect of coronary artery disease on COVID-19—prognosis and risk assessment: a systematic review and meta-analysis

L Szarpak, M Mierzejewska, J Jurek, A Kochanowska… - Biology, 2022 - mdpi.com
Simple Summary As of October 2021, over 245 million people have been infected and
nearly 5 million have died due to COVID-19. Atherosclerosis is a lipid-driven chronic …